FDA Grants Orphan Drug Designation to ELC-100 for Pancreatic NETs
FDA Grants Orphan Drug Designation to ELC-100 for Pancreatic NETs | Image Credit: © Sebastian Kaulitzki – stock.adobe.com The FDA has granted orphan drug designation to ELC-100 for the treatment of patients with pancreatic neuroendocrine tumors (NETs). In …